35
Participants
Start Date
February 20, 2024
Primary Completion Date
October 31, 2026
Study Completion Date
November 30, 2026
Semaglutide 2.4 mg, total diet replacement, behavioural intervention
Patients receive a highly specialized interdisciplinary weight loss treatment comprising two phases. Firstly, they engage in a total diet replacement using Nupo for approximately three months to induce a maximal weight loss. After this and for the duration of the entire treatment period, patients receive Semaglutide 2.4 mg and behavioural dietary support to maintain the weight loss and improve health. The total treatment period is two years.
Copenhagen University Hospital, Hvidovre, Hvidovre
Hvidovre University Hospital
OTHER